| Schedule of basic and diluted income per share |
Diluted net income per share is calculated by adjusting the number of weighted average shares outstanding for the dilutive effect of common stock equivalents outstanding for the period, determined using the treasury stock method. Basic and diluted net income per share were computed as follows: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
2023 |
|
2022 |
|
2023 |
|
2022 |
Net income (in thousands) |
|
$ |
167,602 |
|
$ |
153,746 |
|
$ |
467,870 |
|
$ |
412,156 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding - basic |
|
|
31,615,110 |
|
|
32,076,285 |
|
|
31,588,740 |
|
|
32,404,275 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Dilutive effect of common stock equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
RSAs with service-based conditions |
|
|
36,425 |
|
|
17,175 |
|
|
28,040 |
|
|
14,808 |
RSAs with market-based conditions |
|
|
31,918 |
|
|
44,001 |
|
|
25,606 |
|
|
65,677 |
RSAs with performance-based conditions |
|
|
17,663 |
|
|
40,995 |
|
|
16,223 |
|
|
48,232 |
Stock options |
|
|
87,696 |
|
|
101,364 |
|
|
86,247 |
|
|
110,169 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding - diluted |
|
|
31,788,812 |
|
|
32,279,820 |
|
|
31,744,856 |
|
|
32,643,161 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net income per common share |
|
$ |
5.30 |
|
$ |
4.79 |
|
$ |
14.81 |
|
$ |
12.72 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net income per common share |
|
$ |
5.27 |
|
$ |
4.76 |
|
$ |
14.74 |
|
$ |
12.63 |
|
| Summary of shares excluded from the calculation of diluted income per share because their effect would have been anti-dilutive |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
2023 |
|
2022 |
|
2023 |
|
2022 |
Anti-dilutive common stock equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
RSAs with service-based conditions |
|
|
- |
|
|
15,222 |
|
|
3,721 |
|
|
14,782 |
RSAs with market-based conditions |
|
|
- |
|
|
134 |
|
|
2,978 |
|
|
200 |
RSAs with performance-based conditions |
|
|
- |
|
|
14,611 |
|
|
- |
|
|
7,506 |
Stock options |
|
|
- |
|
|
22,280 |
|
|
12,360 |
|
|
20,581 |
Total anti-dilutive common stock equivalents |
|
|
- |
|
|
52,247 |
|
|
19,059 |
|
|
43,069 |
|